$396.17
0.98% today
NYSE, Dec 05, 05:15 pm CET
ISIN
US0367521038
Symbol
ELV

Elevance Health Target price 2024 - Analyst rating & recommendation

Elevance Health Classifications & Recommendation:

Buy
78%
Hold
17%
Sell
4%

Elevance Health Price Target

Target Price $514.06
Price $400.11
Potential
Number of Estimates 18
18 Analysts have issued a price target Elevance Health 2025 . The average Elevance Health target price is $514.06. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 23 analysts: 18 Analysts recommend Elevance Health to buy, 4 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Elevance Health stock has an average upside potential 2025 of . Most analysts recommend the Elevance Health stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 171.34 175.80
9.42% 2.60%
Net Margin 3.41% 3.55%
5.07% 3.99%

16 Analysts have issued a sales forecast Elevance Health 2024 . The average Elevance Health sales estimate is

$176b
Unlock
. This is
1.02% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$178b 2.24%
Unlock
, the lowest is
$173b 0.59%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $171b 9.42%
2024
$176b 2.60%
Unlock
2025
$189b 7.49%
Unlock
2026
$203b 7.61%
Unlock
2027
$229b 12.80%
Unlock

6 Elevance Health Analysts have issued a net profit forecast 2024. The average Elevance Health net profit estimate is

$6.2b
Unlock
. This is
2.03% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$6.3b 0.47%
Unlock
, the lowest is
$6.1b 4.05%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $5.8b 3.87%
2024
$6.2b 6.56%
Unlock
2025
$7.6b 21.95%
Unlock
2026
$8.9b 16.63%
Unlock
2027
$11.2b 26.43%
Unlock

Net Margin

2023 3.41% 5.07%
2024
3.55% 3.99%
Unlock
2025
4.02% 13.24%
Unlock
2026
4.36% 8.46%
Unlock
2027
4.89% 12.16%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 25.22 26.87
3.87% 6.54%
P/E 14.89
EV/Sales 0.64

6 Analysts have issued a Elevance Health forecast for earnings per share. The average Elevance Health <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$26.87
Unlock
. This is
2.04% lower
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$27.30 0.47%
Unlock
, the lowest is
$26.32 4.05%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $25.22 3.87%
2024
$26.87 6.54%
Unlock
2025
$32.77 21.96%
Unlock
2026
$38.22 16.63%
Unlock
2027
$48.33 26.45%
Unlock

P/E ratio

Current 14.58 23.10%
2024
14.89 2.13%
Unlock
2025
12.21 18.00%
Unlock
2026
10.47 14.25%
Unlock
2027
8.28 20.92%
Unlock

Based on analysts' sales estimates for 2024, the Elevance Health stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.64 15.79%
2024
0.64 0.30%
Unlock
2025
0.59 6.96%
Unlock
2026
0.55 7.07%
Unlock
2027
0.49 11.35%
Unlock

P/S ratio

Current 0.53 20.78%
2024
0.53 1.01%
Unlock
2025
0.49 6.97%
Unlock
2026
0.46 7.07%
Unlock
2027
0.40 11.35%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today